Trizivir

Bibliography

• CARPENTER CC, COOPER DA, FISCHL MA et al: Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 283(3):381–390.
   PubMed Web of Science ®Google Scholar
• DUBE MP: Lipodystrophy and insulin resistance in patients with HIV. I Acquit: Immune Defir. Synth-. (2001) 27(5):506–507.
   PubMed Web of Science ®Google Scholar
• BOUFASSA F, DULIOUST A, LASCAUX AS et al.: Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response. HIV Clin. Trials (2001) 2(4):339–345.
   PubMedGoogle Scholar
• MARTINEZ E, MOCROFT A, GARCIA-VIEJO MA et al.: Risk of fipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet (2001) 357(9256):592–598.
   PubMed Web of Science ®Google Scholar
• CHITTICK GE, GILLOTIN C, MCDOWELL JA et al.: Abacavir: absolute bioavailabifity, bioequivalence of three oral formulations and effect of food. Pharmacetherapy (1999) 19(8):932–942.
   PubMed Web of Science ®Google Scholar
• MCDOWELL JA, LOU Y, SYMONDS WS, STEIN DS: Multiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults. Antimicreb. Agents Chemother. (2000) 44(8):2061–2067.
   PubMed Web of Science ®Google Scholar
• VAN PRAAG PM, VAN HEESWIJK RP, JURRIAANS S, LANGE JM, HOETELMANS PM, PRINS JM: Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1. Clin. Infect. Dis. (2001) 33(8):E91–E92.
   Web of Science ®Google Scholar
• YUEN GJ et al: Abacavir/lamivudine/ zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption. Clin. Pharmacol (2001) 41(3):277–288.
   Google Scholar
• CREMIEUX AC et al.: A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults. Pharmacothempy (2001) 21(4):424–430.
   PubMed Web of Science ®Google Scholar
• IZZEDINE H, LAUNAY-VACHER V, AYMARD G, LEGRAND M, DERAY G: Pharmacokinetics of abacavir in HIV-1-infected patients with impaired renal function. Nephron (2001) 89(1):62–67.
   PubMed Web of Science ®Google Scholar
• BART PA, RIZZARDI PG, GALLANT S et al.: Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir. Ther. Drug Monit. (2001) 23(5):553–555.
   PubMed Web of Science ®Google Scholar
• FISCHL MA: Efficacy of combivir plus ziagen bid compared to trizivir bid, for 24 weeks (E554005). 8th Conference on Retrovimses and Opportunistic Infections Chicago, IL, USA (4–8 February 2001)
   Google Scholar
• STASZEWSKI S, KATLAMA C, HARRER T et al.: A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects. AIDS (1998) 12(16):F197–F202.
   Web of Science ®Google Scholar
• HENRY K, WALLACE RJ, BELLMAN P.: Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus Type 1: results of the TARGET Study. J. Infect. Dis. (2001) 183(4):571–578.
   Google Scholar
• CLUMECK N: Long-term virologic suppression with the triple nucleoside HAART regimen of ABC/3TC/ZDV. 5th International Congress on Drug Therapy in HIV Infection. Glasgow, UK (22–26 Ocotber 2000).
   Google Scholar
• STASZEWSKI S et al: Abacavir-lamivudine-zidovudine versus indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial. JAMA (2001) 285(9):1155–1163.
   PubMed Web of Science ®Google Scholar
• VIBHAGOOL A: Abacavir/Combivir is Comparable to Indinavir/Combivir in HIV-1 Infected Antiretroviral Therapy Naive Adults: Preliminary Results of a 48-Week Open-Label Study (CNA3014). 1st IAS Conference on HIV Pathogenesis and Treatment Buenos Aires, Argentina (8–11 July 2001)
   Google Scholar
• BARTLETT J, DEMASIA R, QUINNB J, MOXHAMB C, ROUSSEAUB F: Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS (2001) 15(11):1369–1377.
   PubMed Web of Science ®Google Scholar
• MATHERON SB-VF, KATLAMA C: 48-week results of the CNAF3007/Ecureuil open-label study: Efficacy and safety of the triple nucleoside combination combivir/ abacavir versus combivir/nelfinavir as first-line antiretroviral therapy in HIV-1 infected adults. 5th International Congress on Drug Therapy in HIV Infection Glasgow, UK (22–26 Ocotber 2000).
   Google Scholar
• PARENTI D, RUANE: The Compact Quad, Combivir/Abacavir/Efavirenz (COM/ABC/EFV) - Preliminary 48-Wk Results (C0L30336. 39th Infectious Diseases Socieo, of America (IDSA) San Francisco, CA, USA (25–28 October 2001).
   Google Scholar
• SHAPIRO M, WARD KM, STERN JJ: A near-fatal hypersensitivity reaction to abacavir: case report and literature review. AIDS Read (2001) 11(4):222–226.
   PubMedGoogle Scholar
• ESCAUT L, LIOTIER JY, ALBENGRES E, CHEMINOT N, VITTECOQ D: Abacavir rechallenge has to be avoided in case of hypersensitivity reaction. AIDS (1999) 13(11):1419–1420.
   PubMed Web of Science ®Google Scholar
• FRISSEN PH, DE VRIES J, WEIGEL HM, BRINKMAN K: Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity. AIDS (2001) 15(2):289.
   PubMed Web of Science ®Google Scholar
• PEYRIEERE H, NICOLAS J, SIFFERT M, DEMOLY P, HILLAIRE-BUYS D, REYNES J: Hypersensitivity related to abacavir in two members of a family. Ann. Pharmacother. (2001) 35(10):1291–1292
   PubMed Web of Science ®Google Scholar
• KAKUDA TN: Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin. Titer. (2000) 22(6):685–708.
   Google Scholar
• JOHNSON AA, RAY AS, HANES J et al.: Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J. Biol. Chem. (2001) 276(44):40847–40857.
   PubMed Web of Science ®Google Scholar
• TIKHOMIROV V, NAMEK K, HINDES R: Agranulocytosis induced by abacavir. AIDS (1999) 13(11):1420–1421.
   PubMed Web of Science ®Google Scholar